Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

10.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.7K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

251
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
251
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

115
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of GSE1 as a PAX5 fusion partner and characterization of PAX5 fusion signature in B-cell acute lymphoblastic leukaemia.

British journal of haematology·2026
Same author

MBP1 inhibits AML proliferation through downregulating noncanonical Wnt/Ca<sup>2+</sup> signaling pathway.

Leukemia & lymphoma·2026
Same author

Analysis of the correlation between combined multiple cytokine detection and colorectal cancer.

Scientific reports·2026
Same author

Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice.

Pharmaceutical science advances·2026
Same author

AI-Based D-Amino Acid Substitution for Optimizing Antimicrobial Peptides to Treat Multidrug-Resistant Bacterial Infection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: May 6, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

De Novo Multi-Mechanism Antimicrobial Peptide Design via Multimodal Deep Learning.

Xiaojuan Li1, Haifan Gong2, Yue Wang1

  • 1Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 9, 2026
PubMed
Summary

Artificial intelligence (AI) can now design novel antimicrobial peptides (AMPs) by analyzing their 3D structures and specific activities. This new method combats drug-resistant bacteria with targeted, low-toxicity AMPs.

Keywords:
3D structureantimicrobial peptidede novo designmultimodal deep learningmulti‐mechanism antimicrobial peptide

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
04:17

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

1.7K

Related Experiment Videos

Last Updated: May 6, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
04:17

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

1.7K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Drug Discovery

Background:

  • Antimicrobial peptide (AMP) discovery using artificial intelligence (AI) has not fully leveraged 3D structural data, species-specific activities, and mechanisms.
  • Multidrug-resistant organisms (MDROs) pose a significant threat, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To develop an AI-driven pipeline for de novo design of multi-mechanism AMPs targeting MDROs.
  • To integrate 3D structural features, species-specific activities, and antimicrobial mechanisms into AI-driven AMP discovery.

Main Methods:

  • Construction of the QLAPD database containing sequences, structures, and antimicrobial properties of 12,914 AMPs.
  • Development of a multimodal, multitask, multilabel, and conditionally controlled AMP discovery (M3-CAD) pipeline.
  • Implementation of an innovative 3D voxel coloring method for enhanced structural characterization and physicochemical context capture.

Main Results:

  • The M3-CAD pipeline successfully identified two novel AMPs, QLX-3DV-1 and QLX-3DV-2.
  • These AMPs demonstrated multiple antimicrobial mechanisms, significant activity against MDROs, and low toxicity.
  • In vivo experiments confirmed the efficacy of QLX-3DV-1 and QLX-3DV-2 with limited toxicity.

Conclusions:

  • Integrating 3D structural features and species-specific antimicrobial data significantly enhances AI-driven AMP discovery.
  • The M3-CAD pipeline offers a viable approach for the de novo design of multi-mechanism AMPs to combat MDROs.